A Partner and a Manager at Beghou Consulting contributed a cover story to PM360. Their article includes the five key questions Pharma Companies can ask themselves to ensure they will be able to quickly and successfully launch any newly acquired assets without harming their company’s current product portfolio.
Read the full feature here: Avoid “Merger Mayhem” When Launching Acquired Therapies
